Breaking News

Ferring Pharma Acquires Cytokine PharmaSciences

Adds to pipeline of women’s healthcare products

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Ferring Pharmaceuticals has acquired Cytokine PharmaSciences Inc. (CPSI) and its UK subsidiary Controlled Therapeutics (Scotland) Ltd. (CTS), a global biopharmaceutical company with a particular focus in obstetrics. “This acquisition advances our vision to become the global scientific and commercial leader in reproductive health, and perfectly complements our already strong portfolio of obstetrics products including TRACTOCILE (atosiban) and PABAL (carbetocin). In addition, the acquisition incl...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters